Iron, Oxygen Radicals, and Disease

Advances in Molecular and Cell Biology

Volumn 25, Issue C, 1998, Pages 157-183

  Nelson, Sally K ^a   McCord, Joe M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000026433     PISSN: 15692558     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2558(08)60036-3     Document Type: Article

References (189)

1. Adams Jr. J.D., and Odunze I.N. Oxygen free radicals and Parkinson's disease. Free Radical Biol. Med. 10 (1991) 161-169
2. Aisen P., and Leibman A. Lactoferrin and transferrin: A comparative study. Biochim. Biophys. Acta. 257 (1972) 314-323
3. Ames B.N., Shigenaga M.K., and Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 90 (1993) 7915-7922
4. Annegers J.F., Appel S.H., Perkens P., and Lee J. Amyotrophic lateral sclerosis mortality rates in Harris County, Texas. Adv. Neurol. 56 (1991) 239-243
5. Appelbaum Y.J., Kuvin J., Borman J.B., Uretzky G., and Chevion M. The protective role of neocuproine against cardiac damage in isolated perfused rat hearts. Free Radical Biol. Med. 8 (1990) 133-143
6. Arroyo C.M., Kramer J.H., Dickens B.F., and Weglicki W.B. Identification of free radicals in myocardial ischemia/reperfusion by spin trapping with nitrone DMPO. FEBS Lett. 221 (1987) 101-104
7. Ascherio A., Willett W.C., Rimm E.B., Giovannucci E.L., and Stampfer M.J. Dietary iron intake and risk of coronary disease among men. Circulation 89 (1994) 969-974
8. Aust S.D., Morehouse L.A., and Thomas C.E. Role of metals in oxygen radical reactions. J. Free Radicals Biol. Med. 1 (1985) 3-25
9. Babbs C.F. Role of iron ions in the genesis of teperfusion injury following successful cardiopulmonary resuscitation: preliminary data and a biochemical hypothesis. Ann. Emerg. Med. 14 (1985) 777-783
10. Badylak S.F., Simmons A., Turek J., and Babbs C.F. Protection from reperfusion injury in the isolated rat heart by postischaemic deferoxamine and oxypurinol administration. Cardiovasc. Res. 21 (1987) 500-506
11. Balla G., Jacob H.S., Balla J., Rosenberg M., Nath K., Apple F., Eaton J.W., and Vercellotti G.M. Ferritin-A cytoprotective antioxidant strategem of endothelium. J. Biol. Chem. 267 (1992) 18148-18153
12. Bannister J.V., Bannister W.H., Hill H.A.O., and Thornally P.J. Enhanced production of hydroxyl radicals by the xanthine-xanthine oxidase reaction in the presence of lactoferrin. Biochim. Biophys. Acta. 715 (1982) 116-120
13. Bannister J.V., Bellavite P., Davoli A., Thornally P.J., and Rossi F. The generation of hydroxyl radicals following superoxide production by neutrophil NADPH oxidase. FEBS Lett. 150 (1982) 300-302
14. Benshachar D., Riederer P., and Youdim M.B.H. Iron-melanin interaction and lipid peroxidation-Implications for Parkinson's disease. J. Neurochem. 57 (1991) 1609-1614
15. Bergeron R.J., Streiff R.R., and Elliott G.T. Influence of iron on in vivo proliferation and lethality of L1210 cells. J. Nutr. 115 (1985) 369-374
16. 31P nuclear resonance study. Circulation 78 (1988) III164-III172 Suppl. 5
17. Bernier M., Hearse D.J., and Manning A.S. Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart. Circ. Res. 58 (1986) 331-340
18. Biemond P., Van Eijk H.G., Swaak A.J.G., and Koster J.F. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases. J. Clin. Invest. 73 (1984) 1576-1579
19. Biemond P., Swaak A.J., Beindorff C.M., and Koster J.F. Superoxide-dependent and -independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Implications for oxygen-free-radical-induced tissue destruction during ischaemia and inflammation. Biochem. J. 239 (1986) 169-173
20. Biemond P., Swaak A.J., Van Eijk H.G., and Koster J.F. Superoxide dependent iron release from ferritin in inflammatory diseases. Free Radical Biol. Med. 4 (1988) 185-198
21. Blumberg B.S., Hann H.W., Mildvan D., Mathur U., Lustbader E., and London W.T. Iron and iron binding proteins in persistent generalised lymphadenopathy and AIDS [letter]. Lancet 1 (1984) 347
22. Bobbio-Pallavicini F., Verde G., Spirano P., Losi R., Bosatra M.G., Braschi A., Iotti G., Chiaranda M., and Villa S. Body iron status in critically ill patients: significance of serum ferritin. Intensive Care Med. 15 (1989) 171-178
23. Bolann B.J., and Ulvik R.J. Release of iron from ferritin by xanthine oxidase. Role of the superoxide radical. Biochem. J. 243 (1987) 55-59
24. Bolann B.J., and Ulvik R.J. On the limited ability of superoxide to release iron from ferritin. Eur. J. Biochem. 193 (1990) 899-904
25. Bolli R., Patel B.S., Zhu W.-X., O'Neill P.G., Hartley C.J., Charlat M.L., and Roberts R. The iron chelator desferoxamine attenuates postischemic ventricular dysfunction. Am. J. Physiol. 253 HCP22 (1987) H1372-H1380
26. Bolli R., Patel B.S., Jeroudi M.O., Lai E.K., and McCay P.B. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap a-phenyl N-tert-butyl nitrone. J. Clin. Invest. 82 (1988) 476-485
27. Borchelt D.R., Lee M.K., Slunt H.S., Guamieri M., Xu Z.S., Wong P.C., Brown R.H., Price D.L., Sisodia S.S., and Cleveland D.W. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Nad. Acad. Sci. USA. 91 (1994) 8292-8296
28. Bowling A.C., Barkowski E.E., Mckennayasek D., Sapp P., Horvitz H.R., Beal M.F., and Brown R.H. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis. J. Neurochem. 64 (1995) 2366-2369
29. Braughler J.M., Duncan L.A., and Chase R.L. The involvement of iron in lipid peroxidation. Importance of ferrous ratios in initiation. J. Biol. Chem. 261 (1986) 10282-10289
30. Brieland J.K., and Fantone J.C. Ferrous iron release from transferrin by human neutrophil-derived superoxide anion: Effect of pH and iron saturation. Arch. Biochem. Biophys. 284 (1991) 78-83
31. Britigan B.E., Hassett D.J., Rosen G.M., Hamill D.R., and Cohen M.S. Neutrophil degranulation inhibits potential hydroxyl-radical formation. Relative impact of myeloperoxidase and lactoferrin release on hydroxyl-radical production by iron-supplemented neutrophils assessed by spin-trapping techniques. Biochem. J. 264 (1989) 447-455
32. Brown Jr. R.H., Horvitz H.R., Rouleau G.A., McKenna-Yasek D., Beard C., Sapp P., Haines J.L., Gusella J.F., and Figlewicz D.A. Gene linkage in familial amyotrophic lateral sclerosis: a progress report. Adv. Neurol. 56 (1991) 215-226
33. Buttke T.M., and Sandstrom P.A. Oxidative stress as a mediator of apoptosis. Immunol. Today. 15 (1994) 7-10
34. Cartwright G.E., Lauritsen M.A., Jones P.J., Merrill I.M., and Wintrobe M.M. The anemia of infection. I. hypoferremia, hypercupremia, and alterations in porphyrin metabolism in patients. J. Clin. Invest. 25 (1946) 65-80
35. Cartwright G.E. The anemia of chronic disorders. Semin. Hematol. 3 (1966) 351-375
36. Cartwright G.E., and Lee G.R. The anaemia of chronic disorders. Br. J. Haematol. 21 (1971) 147-152
37. Casale G., Bignamini M., and de Nicola P. Does blood donation prolong life expectancy? Vox. Sang. 45 (1983) 398-399
38. Cash J.M., and Sears D.A. The anemia of chronic disease: spectrum of associated diseases in a series of unselected hospitalized patients. Am. J. Med. 87 (1989) 638-644
39. Cohen G., Heikkila R.E., Allis B., Cabbat F., Dembiec D., MacNamee D., Mytilineou C., and Winston B. Destruction of sympathetic nerve terminals by 6-hydroxydopamine: Protection by 1-phenyl-3-(2-thiazolyl)-2-thiourea, diethyldithiocarbamate, methimazole, cysteamine, ethanol and n-butanol. J. Pharmacol. Exp. Ther. 199 (1976) 336-352
40. Cohen G. The pathobiology of Parkinson's disease: Biochemical aspects of dopamine neuron senescence. J. Neural. Transm [Suppl]. 19 (1983) 89-103
41. Cohen G., and Heikkila R.E. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J. Biol. Chem. 249 (1974) 2447-2452
42. Cook J.D., Finch C.A., and Smith N.J. Evaluation of the iron status of a population. Blood 48 (1976) 449-455
43. Davidson B.J., Hsu T.C., and Schantz S.P. The genetics of tobacco-induced malignancy. Arch. Otolaryngol. Head. Neck. Surg. 119 (1993) 1198-1205
44. de Sousa M., and Potaznik D. Proteins of the metabolism of iron, cells of the immune system and malignancy. In: Prasad K. (Ed). Vitamins, Nutrition, and Cancer (1984), Karger, Basel 231-239
45. Dexter D.T., Carter C.J., Wells F.R., Javoy-Agid F., Agid Y., Lees A., Jenner P., and Marsden C.D. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52 (1989) 381-389
46. Dexter D.T., Carayon A., Javoy-Agid F., Agid Y., Wells F.R., Daniel S.E., Lees A.J., Jenner P., and Marsden C.D. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114 (1991) 1953-1975
47. Diamond L.S., Harlow D.R., Phillips B.R., and Keister D.B. Entamoeba histolytica-iron and nutritional immunity. Arch. Invest. Med. (Mex). i suppl. 1 (1978) 328-329
48. Durrleman S., and Alperovitch A. Increasing trend of ALS in France and elsewhere: are the changes real?. Neurology. 39 (1989) 768-773
49. Easley R.M., Schreiner B.F., and Yu P.N. Reversible cardiomyopathy associated with hemochromatosis. N. Engl. J. Med. 287 (1972) 866-867
50. Fahn S., and Cohen G. The oxidant stress hypothesis in Parkinson's disease-Evidence supporting it. Ann. Neurol. 32 (1992) 804-812
51. Farber N.E., Vercellotti G.M., Jacob H.S., Pieper G.M., and Gross G.J. Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the canine heart. Circ. Res. 63 (1988) 351-360
52. Faulkner K.M., Stevens R.D., and Fridovich I. Characterization of Mn(III) complexes of linear and cyclic desferrioxamines as mimics of superoxide dismutase activity. Arch. Biochem. Biophys. 310 (1994) 341-346
53. Ferrali M., Ciccoli L., and Comporti M. Allyl alcohol-induced hemolysis and its relation to iron release and lipid peroxidation. Biochem. Pharmacol. 38 (1989) 1819-1825
54. Ferrali M., Ciccoli L., Signorini C., and Comporti M. Iron release and erythrocyte damage in allyl alcohol intoxication in mice. Biochem. Pharmacol. 40 (1990) 1485-1490
55. Ferrali M., Signorini C., Ciccoli L., and Comporti M. Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil. Biochem. J. 285 (1992) 295-301
56. Fielding S., Short C., Davies K., Wald N., Bridges B.A., and Waters R. Studies on the ability of smoke from different types of cigarettes to induce DNA single-strand breaks in cultured human cells. Mutat. Res. 214 (1989) 147-151
57. Fuller B.J., Lunec J., Healing G., Simpkin S., and Green C.J. Reduction of susceptibility to lipid peroxidation by desferoxamine in rabbit kidneys subjected to 24-hour cold ischemia and reperfusion. Transplantation 43 (1987) 604-606
58. Gallagher J.P., and Sanders M. Trauma and amyotrophic lateral sclerosis: A report of 78 patients. Acta Neurol. Scand. 75 (1987) 145-150
59. Garlick P.B., Davies M.J., Hearse D.J., and Slater T.F. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ. Res. 61 (1987) 757-760
60. Golden M.H.N., and Ramdath D. Free radicals in the pathogenesis of kwashiorkor. Proc. Nutr. Soc. 46 (1987) 53-68
61. Green C.J., Healing G., Simpkin S., Fuller B.J., and Lunec J. Reduced susceptibility to lipid peroxidation in cold ischemic rabbit kidneys after addition of desferrioxamine, mannitol, or uric acid to the flush solution. Cryobiology 23 (1986) 358-365
62. Grill H.P., Zweier J.L., Kuppusamy P., Weisfeldt M.L., and Flaherty J.T. Direct measurement of myocardial free radical generation in an in vivo model-Effects of postischemic reperfusion and treatment with human recombinant superoxide dismutase. J. Am. Coll. Cardiol. 20 (1992) 1604-1611
63. Gurney M.E., Pu H.F., Chiu A.Y., Dalcanto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., Chen W.J., Zhai P., Sufit R.L., and Siddique T. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
64. Gutteridge J.M.C. Iron promoters of theFenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett. 201 (1986) 291-295
65. Halliwell B., and Gutteridge J.M. The importance of free radicals and catalytic metal ions in human diseases. Mol. Aspects. Med. 8 (1985) 89-193
66. Halliwell B., and Gutteridge J.M.C. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch. Biochem. Biophys. 246 (1986) 501-514
67. Halliwell B., and Gutteridge J.M.C. Iron as a biological pro-oxidant. ISI Atlas Sci. Biochem. 1 (1988) 48-52
68. Hann H.L., Stahlhut M.W., and Blumberg B.S. Iron nutrition and tumor growth:decreased tumor growth in iron-deficient mice. Cancer Res. 48 (1988) 4168-4170
69. Harris L.R., Cake M.H., and Macey D.I. Iron release from ferritin and its sensitivity to superoxide ions differs among vertebrates. Biochem. J. 301 (1994) 385-389
70. +) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem. Biophys. Res. Commun. 170 (1990) 1049-1055
71. Healing G., Gower J., Fuller B., and Green C. Intracellular iron redistribution. An important determinant of reperfusion damage to rabbit kidneys. Biochem. Pharmacol. 39 (1990) 1239-1245
72. Heikkila R.E., and Cohen G. 6-Hydroxydopamine: Evidence for superoxide radical as an oxidative intermediate. Science 181 (1973) 456-457
73. Hobbs A.J., Fukuto J.M., and Ignarro L.J. Formation of free nitric oxide from L-arginine by nitric oxide synthase: Direct enhancement of generation by superoxide dismutase. Proc. Natl. Acad. Sci. USA 91 (1994) 10992-10996
74. Hokfelt T., and Ungerstedt U. Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurones: an electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro- striatal dopamine system. Brain Res. 60 (1973) 269-297
75. Hollan S., and Johansen K.S. Adequate iron stores and the 'nil nocere' principle. Hematologia. 25 (1993) 69-84
76. Horton W.A., Eldridge R., and Brody J.A. Familial motor neuron disease. Neurology 26 (1976) 460-465
77. Hoy T.G., and Jacobs A. Ferritin polymers and the formation of haemosiderin. Br. J. Haematol. 49 (1981) 593-602
78. Husquinet H., and Franck G. Hereditary amyotrophic lateral sclerosis transmitted for five generations. Clin. Genet. 18 (1980) 109-115
79. Jacobs A. The pathology of iron overload (1980), Academic. Press, London., & New York. 427-459
80. Jenner P., Dexter D.T., Sian J., Schapira A.H.V., and Marsden C.D. Oxidative stress as acause of nigral cell death in Parkinson's disease and incidental lewy body disease. Ann. Neurol. 32 (1992) S82-S87
81. Kahana E., and Zilber N. Changes in the incidence of amyotrophic lateral sclerosis in Israel. Arch. Neurol. 41 (1984) 157-160
82. Kanner J., Harel S., and Granit R. Nitric oxide as an antioxidant. Arch. Biochem. Biophys. 289 (1991) 130-136
83. Krause G.S., Joyce K.M., Nayini N.R., Zonia C.L., Garritano A.M., Hoehner T.J., Evans A.T., Indreri R.J., Huang R.R., Aust S.D., and White B.C. Cardiac arrest and resuscitation: brain iron derealization during reperfusion. Ann. Emerg. Med. 14 (1985) 1037-1043
84. Kurtzke J.F. Risk factors in amyotrophic lateral sclerosis. Adv. Neurol. 56 (1991) 245-270
85. + and paraquat on mitochondrial potential and oxidative stress. Life Sci. 44 (1989) 1277-1284
86. Langston J.W., Ballard P., Tetrad J.W., and Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
87. Lapenna D., Degioia S., Mezzetti A., Ciofani G., Consoli A., Marzio L., and Cuccurullo F. Cigarette smoke, ferritin, and lipid peroxidation. Am. J. Respir. Crit. Care Med. 151 (1995) 431-435
88. Lauffer R.B. Iron stores and the international variation in mortality from coronary artery disease. Med. Hypotheses 35 (1991) 96-102
89. Lauffer R.B., and Sullivan J.L. Iron depletion and coronary disease. Am. Heart J. 119 (1990) 1448-1449
90. Leanderson P., and Tagesson C. Cigarette smoke-induced dna damage in cultured human lung cells -role of hydroxyl radicals and endonuclease activation. Chem. Biol. Interact. 81 (1992) 197-208
91. Lee G.R. The anemia of chronic disease. Semin. Hematol. 20 (1983) 61-80
92. Lee M.H., and Means R.T. Extremely elevated serum ferritin levels in a university hospital: Associated diseases and clinical significance. Am. J. Med. 98 (1995) 566-571
93. Lehr H.A., Kress E., Menger M.D., Friedl H.P., Hubner C., Arfors K.E., and Messmer K. Cigarette smoke elicits leukocyte adhesion to endothelium in hamsters-inhibition by Cu, Zn-SOD. Free Radical Biol. Med. 14 (1993) 573-581
94. Lesnefsky E.J., Repine J.E., and Horwitz L.D. Deferoxamine pretreatment reduces canine infarct size and oxidative injury. J. Pharmacol. Exp. Ther. 253 (1990) 1103-1109
95. Lipschitz D.A. The anemia of chronic disease. J. Am. Ger. Soc. 38 (1990) 1258-1264
96. Magnusson M.K., Sigfusson N., Sigvaldason H., Johannesson G.M., Magnusson S., and Thorgeirsson G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 89 (1994) 102-108
97. Marzabadi M.R., Sohal R.S., and Brunk U.T. Effect of alpha-tocopherol and some metal chelators on lipofuscin accumulation in cultured neonatal rat cardiac myocytes. Anal. Cell. Pathol. 2 (1990) 333-346
98. Mayeux R., Denaro J., Hemenegildo N., Marder K., Tang M.X., Cote L.J., and Stern Y. A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch. Neurol. 49 (1992) 492-497
99. McCord J.M. Oxygen-derived free radicals in post-ischemic tissue injury. N. Engl. J. Med. 312 (1985) 159-163
100. McCord J.M. Is iron sufficiency a risk factor in ischemic heart disease. Circulation 83 (1991) 1112-1114
101. McCord J.M., and Day Jr. E.D. Superoxide-dependent production of hydroxyl radical catalyzed by iron-EDTA complex. FEBS Lett. 86 (1978) 139-142
102. McFarlane H., Reddy S., Adcock K.J., Adeshina H., Cooke A.R., and Akene J. Immunity, transferrin, and survival in kwashiorkor. Br. Med. J. 4 (1970) 268-270
103. Means R.T., and Krantz S.B. Altered iron metabolism and the anemia of chronic disease. Blood 79 (1992) 2797
104. Meerson F.Z., Kagan V.E., Kozlov Y.P., Belkina L.M., and Arkhipenko Y.V. The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart. Basic Res. Cardiol. 77 (1982) 465-485
105. Menasche P., Grousset C., Mouas C., and Piwnica A. A promising approach for improving the recovery of heart transplants: Prevention of free radical injury through iron chelation by deferoxamine. J. Thorac. Cardiovasc. Surg. 100 (1990) 13-21
106. Miller R.A., and Britigan B.E. Protease-cleaved iron-transfenin augments oxidant- mediated endothelial cell injury via hydroxyl radical formation. J. Clin. Invest. 95 (1995) 2491-2500
107. Milman N., Sengelov H., and Dombernowsky P. Iron status markers in patients with small cell carcinoma of the lung - relation to survival. Br. J. Cancer. 64 (1991) 895-898
108. Mochizuki H., Imai H., Endo K., Yokomizo K., Murata Y., Hattori N., and Mizuno Y. Iron accumulation in the substantia nigra of 1-methyl-4- phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys. Neurosci. Lett. 168 (1994) 251-253
109. Monteiro H.P., Vile G.F., and Winterbourn C.C. Release of iron from ferritin by semiquinone, anthracycline, bipyridyl, and nitroaromatic radicals. Free Radical Biol. Med. 6 (1989) 587-591
110. Monteiro H.P., and Winterbourn C.C. 6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation. Biochem. Pharmacol. 38 (1989) 4177-4182
111. Moreno J.J., Foroozesh M., Church D.F., and Pryor W.A. Release of iron from ferritin by aqueous extracts of cigarette smoke. Chem. Res. Toxicol. 5 (1992) 116-123
112. Moss M., Kurzner S., Razlog Y., and Lister G. Hypoxanthine and lactate concentrations in lambs during hypoxic and stagnant hypoxia. Am. J. Physiol. 255 (1988) H53-H59
113. Mulder D.W., Kurland L.T., Offord K.P., and Beard C.M. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology. 36 (1986) 511-517
114. Murphy M.E., and Sies H. Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase. Proc. Natl. Acad. Sci. USA 88 (1991) 10860-10864
115. Murray M.J., Murray A., and Murray C.J. The salutary effect of milk on amoebiasis and its reversal by iron. Br. Med. J. (1980) 1351-1352
116. Myers C.L., Weiss S.J., Kirsh M.M., and Shlafer M. Involvement of hydrogen peroxide and hydroxyl radical in the 'oxygen paradox': reduction of creatine kinase release by catalase, allopurinol or deferoxamine, but not by superoxide dismutase. J. Mol. Cell. Cardiol. 17 (1985) 675-684
117. Nelson S.K., Bose S.K., and McCord J.M. The toxicity of high-dose superoxide dismutase suggests that superoxide can both initiate and terminate lipid peroxidation in the reperfused heart. Free Radical Biol. Med. 16 (1994) 195-200
118. Norskov-Lauritsen N., Demant E.J., and Ebbesen P. Mobilization of ferritin-iron by the anticancer agent bleomycin. Biochem. Pharmacol. 36 (1987) 2685-2686
119. O'Connell M., Halliwell B., Moorhouse C.P., Aruoma O.I., Baum H., and Peters T.J. Formation of hydroxyl radicals in the presence of ferritin and haemosiderin. Is haemosiderin formation a biological protective mechanism? Biochem. J. 234 (1986) 727-731
120. O'Connell M.J., Baum H., and Peters T.J. Haemosiderin-like properties of free-radical-modified ferritin. Biochem. J. 240 (1986) 297-300
121. Olakanmi O., McGowan S.E., Hayek M.B., and Britigan B.E. Iron sequestration by macrophages decreases the potential for extracellular hydroxyl radical formation. J. Clin. Invest. 91 (1993) 889-899
122. Omar R., Nomikos I., Piccorelli G., Savino J., and Agarwal N. Prevention of postischaemic lipid peroxidation and liver cell injury by iron chelation. Gut 30 (1989) 510-514
123. Oram J.D., and Reiter B. Inhibition of bacteria by lactoferrin and other iron-chelating agents. Biochim. Biophys. Acta 170 (1968) 351-365
124. Paller M.S., and Hedlund B.E. Role of iron in postischemic renal injury in the rat. Kidney. Int. 34 (1988) 474-480
125. Poirier J., and Barbeau A. A catalyst function for MPTP in superoxide formation. Biochem. Biophys. Res. Commun. 131 (1985) 1284-1289
126. Powers R.H., Stadnicka A., Kalbfleish J.H., and Skibba J.L. Involvement of xanthine oxidase in oxidative stress and iron release during hyperthermic rat liver perfusion. Cancer Res. 52 (1992) 1699-1703
127. Pryor W.A., Stone K., Cross C.E., Machlin L., and Packer L. Oxidants in cigarette smoke-radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite (1993), Tobacco. Smoking., & Nutrition. 686
128. Przedborski S., Kostic V., Jacksonlewis V., Naini A.B., Simonetti S., Fahn S., Carlson E., Epstein C.J., and Cadet J.L. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12 (1992) 1658-1667
129. Reddy B.R., Kloner R.A., and Przyklenk K. Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury. Free Radical Biol. Med. 7 (1989) 45-52
130. Reif D.W., Schubert J., and Aust S.D. Iron release from ferritin and lipid peroxidation by radiolytically generated reducing radicals. Arch. Biochem. Biophys. 264 (1988) 238-243
131. Reif D.W. Ferritin as a source of iron for oxidative damage. Free Radical Biol. Med. 12 (1992) 417-427
132. Reif D.W., and Simmons R.D. Nitric oxide mediates iron release from ferritin. Arch. Biochem. Biophys. 283 (1990) 537-541
133. Riederer P., Sofic E., Rausch W.-D., Schmidt B., Reynolds G.P., Jellinger K., and Youdim M.B.H. Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. J. Neurochem. 52 (1989) 515-520
134. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., and Willett W.C. Vitamin-e consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328 (1993) 1450-1456
135. Robberecht W., Sapp P., Viaene M.K., Rosen D., McKenna-Yasek D., Haines J., Horvitz R., Theys P., and Brown Jr. R. Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 62 (1994) 384-387
136. Rogers J., Lacroix L., Durmowitz G., Kasschau K., Riotakis J., and Bridges K.R. The role of cytokines in the regulation of ferritin expression. Adv. Exp. Med. Biol. 356 (1994) 127-132
137. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis [published erratum appears in Nature 1993 Jul 22;364(6435):362] [see comments]. Nature 362 (1993) 59-62
138. Rothman R.J., Serroni A., and Farber J.L. Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin, that is involved in oxidative cell injury. Mol. Pharmacol. 42 (1992) 703-710
139. Rothstein J.D., Bristol L.A., Hosier B., Brown R.H., and Kuncl R.W. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc. Natl. Acad. Sci. USA 91 (1994) 4155-4159
140. Rubanyi G.M., and Vanhoutte P.M. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am. J. Physiol. 250 (1986) H815-H821
141. Salonen J.T., Nyyssonen K., Korpela H., Tuomilehto J., Seppanen R., and Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86 (1992) 803-811
142. Salonen J.T., Salonen R., Nyyssonen K., and Korpela H. Iron sufficiency is associated with hypertension and excess risk of myocardial infarction: The Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD. Circulation 85 (1992) 864
143. Samet J.M. The epidemiology of lung cancer. Chest 103 (1993) 20S-29S
144. Schiffer D., Attanasio A., Chio A., Migheli A., and Pezzulo T. Ubiquitinated dystrophic neurites suggest corticospinal derangement in patients with amyotrophic lateral sclerosis. Neurosci. Lett. 180 (1994) 21-24
145. Schilling R.F. Anemia of chronic disease: a misnomer. Ann. Int. Med. 115 (1991) 572-573
146. Sears D.A. Anemia of chronic disease. Med. Clin. North Am. 76 (1992) 567-579
147. Selby J.V., and Friedman G.D. Epidemiologic evidence of an association between body iron stores and risk of cancer. Int. J. Cancer 41 (1988) 677-682
148. Sengstock G.J., Olanow C.W., Menzies R.A., Dunn A.J., and Arendash G.W. Infusion of iron into the rat substantia-nigra - nigral pathology and dose-dependent loss of striatal dopaminergic markers. J. Neurosci. Res. 35 (1993) 67-82
149. Shih Y.J., Baynes R.D., Hudson B.G., Flowers C.H., Skikne B.S., and Cook J.D. Serum transferrin receptor is a truncated form of tissue receptor. J. Biol. Chem. 265 (1990) 19077-19081
150. Siddique T., Pericak-Vance M.A., Brooks B.R., Roos R.P., Hung W.Y., Antel J.P., Munsat T.L., Phillips K., Warner K., Speer M., et al. Linkage analysis in familial amyotrophic lateral sclerosis. Neurology. 39 (1989) 919-925
151. Siddique T., Figlewicz D.A., Pericak-Vance M.A., Haines J.L., Rouleau G., Jeffers A.J., Sapp P., Hung W.Y., Bebout J., McKenna-Yasek D., Deng G., Horvitz H.R., Gusella J.F., Brown Jr. R.H., and Roses A.D. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N. Engl. J. Med. 324 (1991) 1381-1384
152. Singer T.P., and Ramsay R.R. Mechanism of the neurotoxicity of MPTP. An update. FEBS Lett. 274 (1990) 1-8
153. Skikne B.S., Flowers C.H., and Cook J.D. Serum transferrin receptor: aquantitative measure of tissue iron deficiency. Blood 75 (1990) 1870-1876
154. Sohal R.S., Marzabadi M.R., Galaris D., and Brunk U.T. Effect of ambient oxygen concentration on lipofuscin accumulation in cultured rat heart myocytes-A novel in vitro model of lipofuscinogenesis. Free Radical Biol. Med. 6 (1989) 23-30
155. Sohal R.S., and Brunk U.T. Lipofuscin as an indicator of oxidative stress and aging. Adv. Exp. Med. Biol. 266 (1990) 17-30
156. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., and Willett W.C. Vitamin-e consumption and the risk of coronary disease in women. N. Engl. J. Med. 328 (1993) 1444-1449
157. Stevens R.G., Beasley R.P., and Blumberg B.S. Iron-binding proteins and risk of cancer in Taiwan. J. Nat. Cancer Inst. 76 (1986) 605-610
158. Stevens R.G., Jones D.Y., Micozzi M.S., and Taylor P.R. Body iron stores and the risk of cancer. N. Engl. J. Med. 319 (1988) 1047-1052
159. Stevens R.G., Graubard B.I., Micozzi M.S., Nerhshi K., and Blumberg B.S. Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int. J. Cancer 56 (1994) 364-369
160. Sullivan J.L. Iron and the sex difference in heart disease risk. Lancet 1 (1981) 1293-1294
161. Sullivan J.L. Iron, plasma antioxidants, and the 'oxygen radical disease of prematurity'. Am. J. Dis. Child. 142 (1988) 1341-1344
162. Sullivan J.L. The iron paradigm of ischemic heart disease. Am. Heart J. 117 (1989) 1177-1188
163. Sullivan J.L. Stored iron and ischemic heart disease-empirical support for a new paradigm. Circulation 86 (1992) 1036-1037
164. Swerts L., and Van den Bergh R. [Familial amytrophic lateral sclerosis. A study of a family suffering from this disease for three generations]. J. Genet. Hum. 24 (1976) 247-255
165. Takahashi H., Makifuchi T., Nakano R., Sato S., Inuzuka T., Sakimura K., Mishina M., Honma Y., Tsuji S., and Ikuta F. Familial amyotrophic lateral sclerosis with a mutation in the Cu/Zn superoxide dismutase gene. Acta Neuropathol. 88 (1994) 185-188
166. Tandan R., and Bradley W.G. Amyotrophic lateral sclerosis: Part 2. Etiopathogenesis. Ann. Neurol. 18 (1985) 419-431
167. Tandan R., and Bradley W.G. Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management. Ann. Neurol. 18 (1985) 271-280
168. Tavazzi B., Lazzarino G., Dipierro D., and Giardina B. Malondialdehyde production and ascorbate decrease are associated to the reperfusion of the isolated postischemic rat heart. Free Radical Biol. Med. 13 (1992) 75-78
169. Temlett J.A., Landsberg J.P., Watt F., and Grime G.W. Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis. J. Neurochem. 62 (1994) 134-146
170. Thomas C.E., Morehouse L.A., and Aust S.D. Ferritin and superoxide-dependent lipid peroxidation. J. Biol. Chem. 260 (1985) 3275-3280
171. Thomas C.E., and Aust S.D. Reductive release of iron from ferritin by cation free radicals of paraquat and other bipyridyls. J. Biol. Chem. 261 (1986) 13064-13070
172. Thompson A.B., Bohling T., Heires A., Linder J., and Rennard S.I. Lower respiratory tract iron burden is increased in association with cigarette smoking. J. Lab. Clin. Med. 117 (1991) 493-499
173. Thompson H.J., Kennedy K., Witt M., and Juzefyk J. Effect of dietary iron deficiency or excess on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis 12 (1991) 111-114
174. Van der Kraaij A.M.M., Mostert L.J., Van Eijk H.G., and Koster J.F. Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage: Protection by the antioxidant (+)-cyanidanol-3 and deferoxamine. Circulation 78 (1988) 442-449
175. Vial W.C. Cigarette smoking and lung disease. Am. J. Med. Sci. 291 (1986) 130-142
176. Voogd A., Sluiter W., Van Eijk H.G., and Koster J.F. Low molecular weight iron and the oxygen paradox in isolated rat hearts. J. Clin. Invest. 90 (1992) 2050-2055
177. Voogd A. Iron and the Oxygen Paradox in Ischemic Hearts (1993), CIP-DATA Koninklijke Bibliotheek, Den Haag, Netherlands
178. Walters G.O., Miller F.M., and Worwood M. Serum ferritin concentration and iron stores in normal subjects. J. Clin. Path. 26 (1973) 770-772
179. Weinberg E.D. Iron withholding: a defense against infection and neoplasia. Am. Physiol. Soc. 64 (1984) 65-101
180. Weinberg E.D. Iron, infection, and neoplasia. Clin. Physiol. Biochem. 4 (1986) 50-60
181. Weinberg E.D. Iron depletion-a defense against intracellular infection and neoplasia. Life Sci. 50 (1992) 1289-1297
182. White B.C., Krause G.S., Aust S.D., and Eyster G.E. Postischemic tissue injury by iron-mediated free radical lipid peroxidation. Ann. Emerg. Med. 14 (1985) 804-809
183. Wickramasinghe S.N., Gill D.S., Broom G.N., Akinyanju O.O., and Grange A. Limited value of serum ferritin in evaluating iron status in children with protein-energy malnutrition. Scand. J. Haematol. 35 (1985) 292-298
184. Williams R.E., Zweier J.L., and Flaherty J.T. Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts. Circulation 83 (1991) 1006-1014
185. Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., and Price D.L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14 (1995) 1105-1116
186. 2and superoxide dismutase on reperfusion injury of warm ischemic lung. Ann. Thorac. Surg. 54 (1992) 921-924
187. Yoshida S., Mulder D.W., Kurland L.T., Chu C.P., and Okazaki H. Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984. Neuroepidemiology. 5 (1986) 61-70
188. Youdim M.B.H., Ben-Shachar D., and Riederer P. Iron in brain function and dysfunction with emphasis on Parkinson's disease. Eur. Neurol., 31 Suppl. 1 (1991) 34-40
189. Youdim M.B.H., Benshachar D., and Riederer P. The possible role of iron in the etiopathology of Parkinson's disease-review. Movement. Disord. 8 (1993) 1-12